Inhibition of IFN-γ-inducible protein-10 abrogates colitis in IL-10-/- mice

Journal of Immunology

Volumn 171, Issue 3, 2003, Pages 1401-1406

  Singh, Udai P ^a   Singh, Shailesh ^a   Taub, Dennis D ^b   Lillard Jr , James W ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON CROHN DISEASE; COLON MUCOSA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HISTOLOGY; IMMUNOTHERAPY; INFLAMMATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0041845066     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.3.1401     Document Type: Article

References (47)

1. Podolsky, D. K. 1991. Inflammatory bowel disease (1). N. Engl. J. Med. 325:928.
2. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263.
3. Elson, C. O., R. B. Sartor, G. S. Tennyson, and R. H. Riddell. 1995. Experimental models of inflammatory bowel disease. Gastroenterology 109:1344.
4. Blumberg, R. S., L. J. Saubermann, and W. Strober. 1999. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease. Curr. Opin. Immunol. 11:648.
5. + T cells. J. Exp. Med. 178:237.
6. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744.
7. Wiekowski, M. T., M. W. Leach, E. W. Evans, L. Sullivan, S. C. Chen, G. Vassileva, J. F. Bazan, D. M. Gorman, R. A. Kastelein, S. Narula, and S. A. Lira. 2001. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166:7563.
8. Fuss, I. J., R. O. Ehrhardt, M. Neurath, M. Boirivant, B. R. Ludviksson, and W. Strober. 1998. The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease. Scand. J. Immunol. 48:453.
9. Luster, A. D., and J. V. Ravetch. 1987. Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J. Exp. Med. 166:1084.
10. Farber, J. M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukocyte Biol. 61:246.
11. Bonecchi, R., G. Bianchi, P. P. Bordignon, D. D'ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P. A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129.
12. Qin, S., J. B. Rottman, P. Myers, N. Kassam, M. Weinblatt, M. Loetscher, A. E. Koch, B. Moser, and C. R. Mackay. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746.
13. Sorensen, T. L., M. Tani, J. Jensen, V. Pierce, C. Lucchinetti, V. A. Folcik, S. Qin, J. Rottman, F. Sellebjerg, R. M. Strieter, et al. 1999. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:807.
14. Soto, H., W. Wang, R. M. Strieter, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, J. Hedrick, and A. Zlotnik. 1998. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc. Natl. Acad. Sci. USA 95:8205.
15. Uguccioni, M., P. Gionchetti, D. F. Robbiani, F. Rizzello, S. Peruzzo, M. Campieri, and M. Baggiolini. 1999. Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am. J. Pathol. 155:331.
16. Cominelli, F., and T. T. Pizarro. 1997. Interleukin-1 receptor antagonist: a "novel" acute phase protein with antiinflammatory activities. J. Clin. Invest. 99:2813.
17. Gionchetti, P., F. Rizzello, A. Venturi, M. Campieri, and V. Arienti. 2000. Probiotics in infective diarrhoea and inflammatory bowel diseases: ultrasonographic findings in Crohn's disease. J. Gastroenterol. Hepatol. 15:489.
18. Burns, R. C., J. Rivera-Nieves, C. A. Moskaluk, S. Matsumoto, F. Comineiii, and K. Ley. 2001. Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-I/Yit adoptive transfer model of Crohn's disease in mice. Gastroenterology 121:1428.
19. + TH1-like responses. J. Clin. Invest. 98:1010.
20. Lillard, J. W., Jr., P. N. Boyaka, D. D. Taub, and J. R. McGhee. 2001. RANTES potentiates antigen-specific mucosal immune responses. J. Immunol. 166:162.
21. Lillard, J. W., Jr., P. N. Boyaka, J. A. Hedrick, A. Zlotnik, and J. R. McGhee. 1999. Lymphotactin acts as an innate mucosal adjuvant. J. Immunol. 162:1959.
22. + T cells. Immunity 1:553.
23. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184:241.
24. Loetscher, M., D. F. Legler, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1997. Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J. Biol. Chem. 272:17251.
25. + T-cell response to hepatitis δ virus: identification of multiple epitopes and characterization of T-helper cytokine profiles. Curr. Opin. Immunol. 9:10.
26. Snapper, C. M., and W. E. Paul. 1987. Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944.
27. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
28. Stuber, E. R., W. Strober, and M. F. Neurath. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. Immunol. Today 16:564.
29. Ehrhardt, R. O., B. R. Ludviksson, B. Gray, M. Neurath, and W. Strober. 1997. Induction and prevention of colonic inflammation in IL-2-deficient mice. J. Immunol. 158:566.
30. Davidson, N. J., S. A. Hudak, R. E. Lesley, S. Menon, M. W. Leach, and D. M. Rennick. 1998. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161:3143.
31. Okamura, H., H. Tsutsui, S. Kashiwamura, T. Yoshimoto, and K. Nakanishi. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:281.
32. Mouser, J. F., and J. S. Hyams. 1999. Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's disease. Clin. Ther. 21:932.
33. Breese, E. J., C. A. Michie, S. W. Nicholls, S. H. Murch, C. B. Williams, P. Domizio, J. A. Walker-Smith, and T. T. MacDonald. 1994. Tumor necrosis factor α-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455.
34. Reimund, J. M., C. Wittersheim, S. Dumont, C. D. Muller, J. S. Kenney, R. Baumann, P. Poindron, and B. Duclos. 1996. Increased production of tumor necrosis factor-α interleukin-1β, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease. Gut 39:684.
35. Baumgart, D. C., L. D. McVay, and S. R. Carding. 1998. Mechanisms of immune cell-mediated tissue injury in inflammatory bowel disease. Int. J. Mol. Med. 1:315.
36. Pepys, M. B., P. N. Hawkins, and L. B. Lovat. 1997. Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease. Dig. Dis. Sci. 15:155.
37. De Beer, F. C., R. K. Mallya, E. A. Fagan, J. G. Lanham, G. R. Hughes, and M. B. Pepys. 1982. Serum amyloid-A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 2:231.
38. Mandelstam, P., D. E. Simmons, and B. Mitchell. 1989. Regression of amyloid in Crohn's disease after bowel resection: a 19-year follow-up. J. Clin. Gastroenterol. 11:324.
39. Casini-Raggi, V., L. Kam, Y. J. Chong. C. Fiocchi, T. T. Pizarro, and F. Cominelli. 1995. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease: a novel mechanism of chronic intestinal inflammation. J. Immunol. 154:2434.
40. high T cells. Eur. J. Immunol. 31:1465.
41. + T cells and proinflammatory Th1-type cytokines. J. Immunol. 158:1068.
42. Fort, M., R. Lesley, N. Davidson, S. Menon, F. Brombacher, M. Leach, and D. Rennick. 2001. IL-4 exacerbates disease in a Th1 cell transfer model of colitis. J. Immunol. 166:2793.
43. Luster, A. D., S. C. Jhanwar, R. S. Chaganti, J. H. Kersey, and J. V. Ravetch. 1987. Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc. Natl. Acad. Sci. USA 84:2868.
44. Taub, D. D., A. R. Lloyd, K. Conlon, J. M. Wang, J. R. Ortaldo, A. Harada, K. Matsushima, D. J. Kelvin, and J. J. Oppenheim. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177:1809.
45. Cole, K. E., C. A. Strick, T. J. Paradis, K. T. Ogborne, M. Loetscher, R. P. Gladue, W. Lin, J. G. Boyd, B. Moser, D. E. Wood, et al. 1998. Interferon-inducible T cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:2009.
46. Cassatella, M. A., S. Gasperini, F. Calzetti, A. Bertagnin, A. D. Luster, and P. P. McDonald. 1997. Regulated production of the interferon-γ-inducible protein-10 (IP-10) chemokine by human neutrophils. Eur. J. Immunol. 27:111.
47. Gasperini, S., M. Marchi, F. Calzetti, C. Laudanna, L. Vicentini, H. Olsen, M. Murphy, F. Liao, J. Farber, and M. A. Cassatella. 1999. Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell α chemoattractant (I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162:4928.